Event-Driven Stocks

Cyclerion Therapeutics, Inc.

CYCNNasdaqCompleted

MergerMerger / acquisition — shareholder vote (DEFM14A)

Sector
Healthcare
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
State of incorporation
MA
Form
DEFM14A
Filed
June 20, 2023

Deal approval & antitrust

merger-arb risk

A change of control closes only once its regulators clear it. These agencies have jurisdiction given the company's sector — track each one's docket for this deal. We link the official source; we do not assert an outcome.

Filings & documents

Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.